Selection of Peptide Ligands Binding to Fibroblast Growth Factor Receptor 1

Inappropriate expression of fibroblast growth factors (FGFs) or activation of FGF receptors (FGFRs) could contribute to several human angiogenic pathologies. In an attempt to design antagonists of FGF, we developed a screening procedure for identifying peptide ligands binding to FGFR1. To retain the natural conformation of FGFR1 during screening, we expressed recombinant FGFR1 on the surface of Sf9 insect cells. A 6‐mer phage display peptide library was then screened on the cell surface and a group of hydrophobic peptide sequences were identified. Further experiments demonstrated that the phages displaying these sequences can specifically bind to FGFR1. The docking analysis suggests that the peptide ValTyrMetSerProPhe can specifically bind to the hydrophobic surface of FGFR1. The synthetic peptide Ac‐ValTyrMetSerProPhe‐NH 2 can inhibit mitogenic activity of aFGF and has the potential to become a therapeutic agent as an aFGF antagonist.

[1]  A. F. Williams,et al.  The immunoglobulin superfamily--domains for cell surface recognition. , 1988, Annual review of immunology.

[2]  A. Ullrich,et al.  Growth factor receptor tyrosine kinases. , 1988, Annual review of biochemistry.

[3]  J. Scott,et al.  Searching for peptide ligands with an epitope library. , 1990, Science.

[4]  M. Klagsbrun,et al.  Regulators of angiogenesis. , 1991, Annual review of physiology.

[5]  M. Jaye,et al.  Fibroblast growth factor receptor tyrosine kinases: molecular analysis and signal transduction. , 1992, Biochimica et biophysica acta.

[6]  J. Xu,et al.  Substitution of putative half-cystine residues in heparin-binding fibroblast growth factor receptors. Loss of binding activity in both two and three loop isoforms. , 1992, The Journal of biological chemistry.

[7]  D. Givol,et al.  Complexity of FGF receptors: genetic basis for structural diversity and functional specificity , 1992, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[8]  W. Fantl,et al.  Signalling by receptor tyrosine kinases. , 1993, Annual review of biochemistry.

[9]  E. Katchalski‐Katzir,et al.  Isolation of peptides that inhibit binding of basic fibroblast growth factor to its receptor from a random phage-epitope library. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[10]  R. Abagyan,et al.  Biased probability Monte Carlo conformational searches and electrostatic calculations for peptides and proteins. , 1994, Journal of molecular biology.

[11]  S. Rosenberg,et al.  High-affinity urokinase receptor antagonists identified with bacteriophage peptide display. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[12]  G. Winter,et al.  Isolation of a peptide antagonist to the thrombin receptor using phage display. , 1994, Journal of molecular biology.

[13]  Hui Zhang,et al.  A new computational model for protein folding based on atomic solvation , 1995, Protein science : a publication of the Protein Society.

[14]  Doherty,et al.  CAM-FGF Receptor Interactions: A Model for Axonal Growth , 1996, Molecular and cellular neurosciences.

[15]  C. Turck,et al.  A natural kinase-deficient variant of fibroblast growth factor receptor 1. , 1996, Biochemistry.

[16]  F. Gage,et al.  A 10-amino acid sequence of fibroblast growth factor 2 is sufficient for its mitogenic activity on neural progenitor cells. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[17]  S. Hubbard,et al.  Structural Basis for FGF Receptor Dimerization and Activation , 1999, Cell.

[18]  Y. Liu,et al.  Selection of Peptide Ligands That Bind to Acid Fibroblast Growth Factor , 2000, IUBMB life.

[19]  David F. Burke,et al.  Crystal structure of fibroblast growth factor receptor ectodomain bound to ligand and heparin , 2000, Nature.

[20]  Jingming Zhang,et al.  Disulfide Bond Formation of a Hydrophobic Peptide by Dimethyl Sulfoxide , 2001 .

[21]  E. Battegay,et al.  Angiogenesis: mechanistic insights, neovascular diseases, and therapeutic prospects , 1995, Journal of Molecular Medicine.